Compare THS & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | THS | LMAT |
|---|---|---|
| Founded | 2021 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.9B |
| IPO Year | N/A | 2006 |
| Metric | THS | LMAT |
|---|---|---|
| Price | $23.49 | $80.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $24.67 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 658.7K | 180.5K |
| Earning Date | 02-13-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | N/A | ★ 27.40 |
| EPS | N/A | ★ 2.32 |
| Revenue | ★ $3,336,000,000.00 | $240,866,000.00 |
| Revenue This Year | $1.43 | $15.17 |
| Revenue Next Year | $0.71 | $9.07 |
| P/E Ratio | ★ N/A | $34.56 |
| Revenue Growth | N/A | ★ 13.07 |
| 52 Week Low | $15.85 | $71.42 |
| 52 Week High | $40.77 | $105.55 |
| Indicator | THS | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.58 | 33.49 |
| Support Level | $23.46 | $83.33 |
| Resistance Level | $23.82 | $86.00 |
| Average True Range (ATR) | 0.18 | 2.17 |
| MACD | -0.13 | -0.23 |
| Stochastic Oscillator | 4.76 | 10.18 |
TreeHouse Foods is the largest pure-play private-label manufacturer in the US. Much larger in the past following the 2016 acquisition of Ralcorp, Conagra's former private-label business, the company has since divested several businesses to focus on high-growth categories. At present, the company produces and sells snacks (crackers, pretzels, cookies, and so on), beverages (such as nondairy creamer, coffee, tea, broth), and a select number of grocery products (pickles, refrigerated dough, hot cereal, cheese, and pudding). Its most important sales channel is through retail grocery stores that sell its products under their own brands, with co-manufacturing and food away from home as much smaller channels of distribution for its fare.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.